Ovarian tumour cells thus preferentially synthesise factor H-like protein, the alternatively spliced short variant of factor H. The tumour cells were found to bind both 125I-labelled factor H and recombinant factor H-like protein to their surfaces. Here, CFH is linked to neoplasm.